Viking Therapeutics, Inc. Interest Payable, Current
Viking Therapeutics, Inc. (VKTX) had Interest Payable, Current of $34.00 thousand as of 2018-03-31, per its 10-Q filed 2018-05-09.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:InterestPayableCurrent · last filed 2019-03-13
- 2018-03-31: Interest Payable, Current $34.00K.
- 2017-12-31: Interest Payable, Current $22.00K; Interest Payable, Current as first filed $21.96K.
- 2017-09-30: Interest Payable, Current $9.98K.
- 2017-06-30: Interest Payable, Current $59.33K.
| Period end | Interest Payable, Current | Interest Payable, Current as first filed |
|---|---|---|
| 2018-03-31 | $34.00K 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $22.00K 10-K · filed 2019-03-13 | $21.96K 10-K · filed 2018-03-07 |
| 2017-09-30 | $9.98K 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $59.33K 10-Q · filed 2017-08-09 | |
| 2016-12-31 | $34.89K 10-K · filed 2018-03-07 | |
| 2016-09-30 | $22.67K 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $10.46K 10-Q · filed 2016-08-11 | |
| 2015-09-30 | $152.36K 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $121.11K 10-Q · filed 2015-08-14 | |
| 2015-03-31 | $112.47K 10-Q · filed 2015-06-12 | |
| 2014-12-31 | $77.22K 10-K · filed 2016-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Indivior Pharmaceuticals, Inc. (INDV) | $4.250B | 14.09 | |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |